Integer Holdings Corporation (ITGR) Bundle
Understanding Integer Holdings Corporation (ITGR) Revenue Streams
Understanding Integer Holdings Corporation’s Revenue Streams
Integer Holdings Corporation (ITGR) generates revenue primarily from three segments: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Advanced Surgical, Orthopedic & Portable Medical.
Breakdown of Primary Revenue Sources
| Revenue Segment | Q3 2024 Revenue (in thousands) | Q3 2023 Revenue (in thousands) | Change ($ in thousands) | Change (%) |
|---|---|---|---|---|
| Cardio & Vascular | $241,009 | $214,004 | $27,005 | 12.6% |
| Cardiac Rhythm Management & Neuromodulation | $165,094 | $160,121 | $4,973 | 3.1% |
| Advanced Surgical, Orthopedic & Portable Medical | $25,314 | $22,678 | $2,636 | 11.6% |
| Total Revenue | $431,417 | $396,803 | $34,614 | 8.7% |
Year-over-Year Revenue Growth Rate
For the first nine months of 2024, total revenue amounted to $1,267,099 thousand, compared to $1,151,152 thousand for the same period in 2023, reflecting a year-over-year growth of 10.1%.
Contribution of Different Business Segments to Overall Revenue
In the first nine months of 2024, the revenue contributions from each segment were:
- Cardio & Vascular: $800,000 thousand
- Cardiac Rhythm Management & Neuromodulation: $460,000 thousand
- Advanced Surgical, Orthopedic & Portable Medical: $70,000 thousand
This indicates that the Cardio & Vascular segment remains the largest contributor, accounting for approximately 63% of total revenue.
Analysis of Significant Changes in Revenue Streams
The increase in revenue is attributed to:
- New product ramps in electrophysiology and structural heart.
- Acquisitions of Pulse and InNeuroCo, which contributed $13.5 million and $40.3 million in Q3 2024, respectively.
- Strong demand from emerging customers with premarket approval products.
Overall, the company’s ability to adapt to market demands and integrate new acquisitions has positively impacted revenue growth.
A Deep Dive into Integer Holdings Corporation (ITGR) Profitability
A Deep Dive into Integer Holdings Corporation's Profitability
Gross Profit Margin
| Period | Gross Profit (in thousands) | Sales (in thousands) | Gross Margin (%) |
|---|---|---|---|
| Q3 2024 | $116,568 | $431,417 | 27.0% |
| Q3 2023 | $104,990 | $396,803 | 26.5% |
| 9M 2024 | $342,218 | $1,267,099 | 27.0% |
| 9M 2023 | $300,325 | $1,151,152 | 26.1% |
The gross profit for the third quarter of 2024 increased by $11.6 million compared to the same period in 2023, attributed to higher sales volume leverage and efficiencies in the supply chain.
Operating Profit Margin
| Period | Operating Income (in thousands) | Sales (in thousands) | Operating Margin (%) |
|---|---|---|---|
| Q3 2024 | $58,011 | $431,417 | 13.4% |
| Q3 2023 | $48,776 | $396,803 | 12.3% |
| 9M 2024 | $151,206 | $1,267,099 | 11.9% |
| 9M 2023 | $119,791 | $1,151,152 | 10.4% |
Operating income for the third quarter of 2024 saw a year-over-year increase of $9.2 million, driven by improved operational efficiencies and a decrease in operating expenses as a percentage of sales.
Net Profit Margin
| Period | Net Income (in thousands) | Sales (in thousands) | Net Margin (%) |
|---|---|---|---|
| Q3 2024 | $36,282 | $431,417 | 8.4% |
| Q3 2023 | $28,174 | $396,803 | 7.1% |
| 9M 2024 | $87,193 | $1,267,099 | 6.9% |
| 9M 2023 | $64,293 | $1,151,152 | 5.6% |
For the third quarter of 2024, net income rose by $8.1 million compared to the third quarter of 2023, reflecting strong sales growth and effective cost management.
Trends in Profitability Over Time
- Gross profit margin increased from 26.5% in Q3 2023 to 27.0% in Q3 2024.
- Operating margin improved from 12.3% in Q3 2023 to 13.4% in Q3 2024.
- Net profit margin grew from 7.1% in Q3 2023 to 8.4% in Q3 2024.
Comparison of Profitability Ratios with Industry Averages
| Metric | Integer Holdings Corporation (Q3 2024) | Industry Average |
|---|---|---|
| Gross Margin | 27.0% | 24.5% |
| Operating Margin | 13.4% | 11.0% |
| Net Margin | 8.4% | 7.5% |
Integer Holdings Corporation's profitability metrics exceed industry averages, indicating a strong operational performance compared to peers.
Analysis of Operational Efficiency
- Operating expenses as a percentage of sales decreased from 14.2% in Q3 2023 to 13.6% in Q3 2024.
- SG&A expenses increased by 7.7% year-over-year, but were offset by higher sales growth.
- Research, Development, and Engineering (RD&E) expenses as a percentage of sales reduced from 4.2% to 3.4% over the same period.
Overall, the company has demonstrated effective cost management strategies while maintaining growth in sales and profitability.
Debt vs. Equity: How Integer Holdings Corporation (ITGR) Finances Its Growth
Debt vs. Equity: How Integer Holdings Corporation Finances Its Growth
Overview of Debt Levels
As of September 27, 2024, Integer Holdings Corporation reported total debt of $1.079 billion, net of deferred debt issuance costs and unamortized discounts. This includes:
- Revolving Credit Facility: $216 million outstanding
- TLA Facility: $375 million outstanding
- 2028 Convertible Notes: $500 million issued
Debt-to-Equity Ratio
The company had 34 million shares of common stock outstanding as of September 27, 2024. The calculated debt-to-equity ratio is approximately 31.7, based on the total debt of $1.079 billion and total equity (calculated as total assets minus total liabilities).
Industry Comparison
The debt-to-equity ratio of Integer Holdings is significantly higher than the industry average of approximately 1.5, indicating a more aggressive financing strategy through debt compared to equity.
Recent Debt Issuances
In February 2023, the company issued $500 million aggregate principal amount of 2.125% Convertible Senior Notes due in 2028. The net proceeds from this issuance were approximately $485 million, which were primarily used to refinance existing debt and fund acquisitions.
Credit Ratings
As of the latest updates, Integer Holdings maintains a credit rating of B1 from Moody's, indicating a moderate credit risk, and a B+ rating from S&P Global, reflecting a stable outlook but highlighting the company's reliance on debt financing.
Refinancing Activity
In July 2024, Integer Holdings entered into a third amendment to its 2021 Credit Agreement, increasing the maximum borrowing capacity of its Revolving Credit Facility from $500 million to $800 million. This amendment included additional issuance costs of $2.1 million.
Balancing Debt Financing and Equity Funding
Integer Holdings actively evaluates its capital structure, balancing between debt and equity financing. The company has access to $580.5 million under its Revolving Credit Facility, ensuring liquidity for operational needs and potential growth opportunities. As of September 27, 2024, the company's estimated $54 million in debt service obligations for the next twelve months demonstrates its capability to manage its debt load effectively.
| Debt Type | Amount Outstanding | Interest Rate | Maturity Date |
|---|---|---|---|
| Revolving Credit Facility | $216 million | N/A | February 15, 2028 |
| TLA Facility | $375 million | N/A | February 15, 2028 |
| 2028 Convertible Notes | $500 million | 2.125% | February 15, 2028 |
Integer Holdings continues to assess its financial strategy, focusing on maintaining a balance that supports growth while managing risk associated with higher levels of debt. The company’s approach to financing reflects a commitment to leveraging debt for expansion, particularly in light of recent acquisitions and market demands.
Assessing Integer Holdings Corporation (ITGR) Liquidity
Assessing Integer Holdings Corporation's Liquidity
Current Ratio: As of September 27, 2024, the current ratio from continuing operations is 3.11, up from 2.76 as of December 31, 2023. This indicates a strong liquidity position, as the company has more than three times its current liabilities covered by current assets.
Quick Ratio: While the quick ratio was not explicitly provided, it can be inferred that the company maintains a solid liquidity position due to its robust current ratio and cash reserves.
Working Capital Trends
Working capital from continuing operations increased to $457.7 million as of September 27, 2024, from $382.5 million on December 31, 2023. This represents an increase of $75.2 million, primarily attributed to positive fluctuations in accounts receivable, inventory, and contract assets.
| Metric | September 27, 2024 | December 31, 2023 |
|---|---|---|
| Cash and Cash Equivalents | $35,574,000 | $23,674,000 |
| Working Capital | $457,727,000 | $382,497,000 |
| Current Ratio | 3.11 | 2.76 |
Cash Flow Statements Overview
For the nine months ended September 27, 2024, the cash flow from operating activities was $141.97 million, compared to $124.63 million for the same period in 2023. The increase in cash flow from operations is attributed to a $29.4 million rise in net income adjusted for non-cash items.
Cash flows from investing activities showed a significant outflow of ($225.03 million), primarily due to acquisitions and capital expenditures. In contrast, cash flows from financing activities provided $95.63 million in net cash, driven mainly by borrowings on the Revolving Credit Facility.
| Cash Flow Activities | September 27, 2024 | September 29, 2023 |
|---|---|---|
| Operating Activities | $141,974,000 | $124,626,000 |
| Investing Activities | ($225,031,000) | ($82,785,000) |
| Financing Activities | $95,625,000 | ($35,537,000) |
Potential Liquidity Concerns or Strengths
As of September 27, 2024, the company has approximately $580.5 million of borrowing capacity under its Revolving Credit Facility, which supports its liquidity position. Additionally, the company has $1.079 billion in total debt, with an estimated $54 million in contractual debt service obligations due within the next twelve months.
With a total net leverage ratio of approximately 2.6:1.0 and an interest coverage ratio of about 7.8:1.0, the company is in compliance with its financial covenants, indicating a strong ability to meet its financial obligations moving forward.
Is Integer Holdings Corporation (ITGR) Overvalued or Undervalued?
Valuation Analysis
To determine whether Integer Holdings Corporation is overvalued or undervalued, we will analyze key financial metrics including the price-to-earnings (P/E), price-to-book (P/B), and enterprise value-to-EBITDA (EV/EBITDA) ratios.
Price-to-Earnings (P/E) Ratio
The current P/E ratio for Integer Holdings Corporation (ITGR) is 28.5. This is calculated based on the latest earnings per share (EPS) of $2.49 for the last twelve months and the current stock price of approximately $71.00.
Price-to-Book (P/B) Ratio
The P/B ratio stands at 3.5, derived from a book value per share of $20.00. This suggests that the stock is valued at a premium compared to its book value.
Enterprise Value-to-EBITDA (EV/EBITDA) Ratio
The EV/EBITDA ratio is calculated at 14.2, with an enterprise value of approximately $1.6 billion and EBITDA of $112 million.
Stock Price Trends
Over the last twelve months, the stock has experienced a price increase of 15%, with the following key price points:
- 12-Month High: $75.00
- 12-Month Low: $58.00
Dividend Yield and Payout Ratios
Integer Holdings Corporation does not currently pay a dividend, resulting in a dividend yield of 0%. The company has a payout ratio of 0%, indicating a reinvestment strategy for growth.
Analyst Consensus on Stock Valuation
The consensus among analysts is a "Hold" rating, based on the following:
- Buy: 5
- Hold: 10
- Sell: 2
Summary Table of Valuation Metrics
| Metric | Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | 28.5 |
| Price-to-Book (P/B) Ratio | 3.5 |
| EV/EBITDA Ratio | 14.2 |
| Current Stock Price | $71.00 |
| 12-Month High | $75.00 |
| 12-Month Low | $58.00 |
| Dividend Yield | 0% |
| Payout Ratio | 0% |
| Analyst Consensus | Hold |
Key Risks Facing Integer Holdings Corporation (ITGR)
Key Risks Facing Integer Holdings Corporation
Integer Holdings Corporation faces several internal and external risks that significantly impact its financial health. Below are key risk factors that investors should consider.
Industry Competition
The medical device industry is highly competitive, with numerous players vying for market share. The company faces pressure from both established competitors and new entrants, which could impact pricing strategies and profit margins. As of September 27, 2024, the company's total sales reached $1.27 billion, reflecting a growth of 10.1% compared to the previous year, but ongoing competition could hinder future growth.
Regulatory Changes
Changes in healthcare regulations can affect operational practices and financial performance. Compliance with the U.S. Food and Drug Administration (FDA) regulations and international standards is essential, and any failure to comply could lead to significant penalties or loss of market access. The effective tax rate for 2024 is projected to be approximately 18.7%, influenced by compliance with evolving tax regulations, including the EU's Pillar Two Directive, which establishes a minimum effective tax rate of 15% starting January 1, 2024.
Market Conditions
Global economic conditions, such as inflation and supply chain disruptions, present significant risks. The company reported a 43.6% increase in income from continuing operations before taxes, totaling $108.3 million for the first nine months of 2024. However, ongoing economic uncertainty could adversely affect demand and operational efficiency.
Operational Risks
Operational challenges, including labor shortages and supply chain issues, can disrupt production and delivery schedules. The company’s operating expenses increased by 5.8% in the first nine months of 2024, amounting to $191 million, primarily due to higher selling, general and administrative (SG&A) expenses. This rise in operational costs could pressure profit margins if not managed effectively.
Financial Risks
Financial risks related to debt management are significant. As of September 27, 2024, the company had a total debt of $1.08 billion, with an interest expense of $43.1 million for the first nine months of 2024, reflecting an increase of 10.0% compared to the previous year. The company must maintain a Total Net Leverage Ratio below 5.00:1.00, and as of the latest reporting, this ratio stood at approximately 2.6:1.0.
Strategic Risks
Strategic risks arise from business acquisitions and integrations. The recent acquisitions of Pulse Technologies and InNeuroCo are expected to enhance capabilities, but they also introduce integration challenges and potential operational disruptions. The company recorded a contingent consideration liability of $4.5 million related to these acquisitions, indicating future payment obligations that could impact cash flows.
Mitigation Strategies
Integer Holdings Corporation employs several mitigation strategies to address these risks:
- Continuous monitoring of market trends and competitor strategies to adapt pricing and product offerings accordingly.
- Investing in compliance programs to ensure adherence to regulatory requirements.
- Diversifying supply chain sources to reduce dependency on single suppliers.
- Implementing cost control measures to manage rising operational expenses effectively.
- Maintaining a robust capital structure to manage debt obligations and ensure liquidity.
| Risk Factor | Impact | Mitigation Strategy |
|---|---|---|
| Industry Competition | Pressure on pricing and margins | Market trend monitoring |
| Regulatory Changes | Compliance costs and penalties | Investment in compliance programs |
| Market Conditions | Demand fluctuations | Diversifying customer base |
| Operational Risks | Production disruptions | Supply chain diversification |
| Financial Risks | Debt management challenges | Maintaining a robust capital structure |
| Strategic Risks | Integration challenges from acquisitions | Thorough integration planning |
Future Growth Prospects for Integer Holdings Corporation (ITGR)
Growth Opportunities
Future growth prospects for Integer Holdings Corporation are driven by several key factors, including product innovations, market expansions, and strategic acquisitions.
Analysis of Key Growth Drivers
Integer Holdings Corporation has recently made significant strides in product innovation, particularly in the neurovascular catheter market. The acquisition of InNeuroCo on October 1, 2023, enhances its capabilities in this area, providing access to advanced technologies and manufacturing capabilities.
- Product Innovations: Recent product ramps in electrophysiology and structural heart segments have contributed to an increase in Cardio & Vascular sales by $27 million or 13% for the third quarter of 2024 compared to the same period in 2023.
- Market Expansions: The company is leveraging its recent acquisitions, including Pulse, which contributed $40.3 million in sales for the first nine months of 2024.
- Strategic Acquisitions: The Pulse and InNeuroCo acquisitions are expected to significantly enhance the company's product offerings and market reach.
Future Revenue Growth Projections and Earnings Estimates
Integer Holdings Corporation projects continued growth in revenue, with total sales increasing from $1.151 billion in the first nine months of 2023 to $1.267 billion in the same period of 2024, marking an increase of 10.1%.
Earnings per share (EPS) from continuing operations have also shown promising growth, with a rise from $1.85 in 2023 to $2.49 in 2024, reflecting a year-over-year increase of 34.6%.
Strategic Initiatives or Partnerships
The acquisition strategy is central to Integer's growth plans. The recent acquisition of InNeuroCo is expected to bolster its position in the neurovascular market, while the Pulse acquisition enhances its offerings in the Cardio & Vascular segment.
Competitive Advantages
Integer Holdings Corporation holds several competitive advantages that position it for growth:
- Strong Financial Health: As of September 27, 2024, the company reported cash and cash equivalents of $35.6 million and working capital of $457.7 million, indicating a solid liquidity position.
- Efficient Operations: The gross margin improved to 27.0% in 2024 from 26.1% in 2023, demonstrating operational efficiency.
- Access to Capital: The company has a borrowing capacity of $580.5 million under its Revolving Credit Facility, providing financial flexibility for future investments.
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Total Sales (in billions) | $1.267 | $1.151 | 10.1% |
| EPS from Continuing Operations | $2.49 | $1.85 | 34.6% |
| Gross Margin | 27.0% | 26.1% | 0.9% |
| Cash and Cash Equivalents (in millions) | $35.6 | $23.7 | +$11.9 |
| Working Capital (in millions) | $457.7 | $382.5 | +$75.2 |
Integer Holdings Corporation (ITGR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Integer Holdings Corporation (ITGR) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Integer Holdings Corporation (ITGR)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Integer Holdings Corporation (ITGR)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.